Navigation Links
Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
Date:11/2/2009

is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

LabChip is a registered trademark of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
2. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
3. Cell Biosciences Completes Acquisition of Alpha Innotech
4. Neurocrine Biosciences Reports Third Quarter 2009 Results
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
6. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
7. Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown, Declares Frost & Sullivan
8. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
9. Northern Light Adds 4,000 Bio-Pharma, Health Sciences and General Business News and Journal Sources from EBSCO Publishing
10. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
11. Prolifiq and EthicsPoint Announce Partnership: Automatic Alerts Help Life Sciences Engage in Good Promotional Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
(Date:7/6/2015)... and SOUTH SAN FRANCISCO, Calif. , ... AGN ), a leading global pharmaceutical company, and Oculeve, ... treatments for dry eye disease, today announced that they ... acquire Oculeve in an all-cash transaction.  Under the terms ... $125 million upfront payment and commercialization milestone payments related ...
(Date:7/6/2015)... July 6, 2015 Akcea Therapeutics, a ... ISIS ), announced today that the U.S. Food ... to volanesorsen (ISIS-APOCIII Rx ) for the treatment ... is a rare genetic disease characterized by extremely ... a Phase 2 study published in the NEJM ...
Breaking Medicine Technology:Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... 2012  Atlanta-based Acella Pharmaceuticals, LLC, announces the addition ... and Marketing of their commercial team. Tom will ... Acella,s product line.    Tom is ... bringing more than 11 years of industry experience, ...
... 2012   Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... 31, 2012 before market open on Tuesday May 8, 2012. ... webcast at 9:00 am Eastern Time (6:00 am Pacific Time) ... Domestic callers: 1 (866) 543-6411 International callers: +1 (617) 213-8900 ...
Cached Medicine Technology:
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is ... area patients. Kybella is a non-surgical method to dissolve fat cells and ... moderate to severe fat deposits under the chin, commonly known as a double chin. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud ... Software Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading ... its future call center platform. , Promero will implement and manage the ...
(Date:7/6/2015)... Newport News, VA (PRWEB) , ... July 06, ... ... announced today that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® ... Bon Secours Mary Immaculate Hospital in Newport News, VA. The procedure was an ...
(Date:7/6/2015)... ... 06, 2015 , ... Diabetes affects many of us and the Glycemic Load ... diabetes, the majority of which are Type 2. However, eight million do not know ... three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar levels ...
(Date:7/6/2015)... Akron, OH (PRWEB) , ... July 06, 2015 , ... ... Home Health and Hospice received the Music & Memory Certification for hospice patients ... bringing the power of music not only to patients but also to their families ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4
... With sights set on advanced science degrees and careers ... now have the highest honor they can garner for ... Eastham, a junior chemistry major, and Thomas Markovich, a ... Barry M. Goldwater Scholars for the 2011-2012 academic year. ...
... 6, 2011 Researchers at The Scripps Research Institute have found ... to pour in and activate an immune response. This process can ... it fallssuch as when immune cells are "called" from the body,s ... The study, recently published online ahead of print by Nature ...
... international panel of experts from The Heart Rhythm Society ... recommendations for all health care professionals about cardiovascular genetic ... Sessions. Silvia G. Priori, MD, PhD, a ... director of the Cardiovascular Genetics Program at NYU Langone ...
... National Academies Keck Futures Initiative announced today the recipients ... to support interdisciplinary research on imaging science. The ... such research, which was the subject of the eighth ... "We received far more high-quality proposals than funds available," ...
... A study published in the June 2011 issue of ... the association between patientphysician gender concordance and weight-related counseling ... and Johns Hopkins University found that obese male patients ... counseling than obese women seeing a female physician. ...
... Reporter , THURSDAY, May 5 (HealthDay News) -- You stand ... while you,re in an exercise facility than if you,re in ... Overall, 50 percent of cardiac arrest victims survived ... sort of exercise was happening, whereas only 36 percent of ...
Cached Medicine News:Health News:2 students named Goldwater Scholars, 2 receive honorable mention 2Health News:2 students named Goldwater Scholars, 2 receive honorable mention 3Health News:Scripps Research scientists show how shifts in temperature prime immune response 2Health News:Scripps Research scientists show how shifts in temperature prime immune response 3Health News:New guidelines for cardiovascular genetic testing 2Health News:Keck Futures Initiative awards $1 million for 13 research projects 2Health News:Keck Futures Initiative awards $1 million for 13 research projects 3Health News:Keck Futures Initiative awards $1 million for 13 research projects 4Health News:Keck Futures Initiative awards $1 million for 13 research projects 5Health News:Weight-loss counseling most prevalent between male physicians and obese men 2Health News:Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds 2Health News:Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds 3
Microforceps: Claes ILM Forceps...
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps with "nail-like" end-gripping platforms; for precise grasping and improved visualization of thin membranes in the macular region....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products: